佩奥尼佛林衍生物通过向GRK2-A2AAR轴来改善在治疗类风湿性关节炎中的甲状腺素抗性
Paipai Guo1, Rui Wang2, Meiyue Lu2
1School of Pharmacy, Institute of Clinical Pharmacology, Anhui Medical University, Key Laboratory of Anti-inflammatory and Immune Medicine, Ministry of Education, Collaborative Innovation Center of Anti-inflammatory and Immune Medicines, Hefei 230032, China; Department of Clinical Pharmacology, The Second Affiliated Hospital of Anhui Medical University, Hefei 230601, China.
概括
高GRK2表达通过损害A2AAR功能,降低了在类风湿性关节炎 (RA) 中的甲状腺激素 (MTX) 疗效. 结合MTX和paeoniflorin衍生物可增强治疗反应,特别是在不反应的RA患者中.
科学领域:
- 类风湿病学 类风湿病学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 甲托雷克萨特 (MTX) 是类风湿性关节炎 (RA) 的主要治疗方法,但大约40-55%的患者表现出有限的疗效.
- 了解MTX不响应对于在RA治疗中推进精准医学至关重要.
研究的目的:
- 调查膜GRK2表达在MTX免疫抑制作用中的作用,由A2AAR介导.
- 为了评估是否可以提高PAeoniflorin衍生物在RA治疗中MTX响应.
主要方法:
- 评估了RA患者对外围血液淋巴细胞 (PBL) 的GRK2和A2AAR表达,与疾病活性和MTX疗效相关.
- 利用原诱导性关节炎 (CIA) 的老鼠模型,将它们分为MTX有效和MTX无效的组.
- 对MTX不响应的老鼠和GRK2-高的CIA老鼠进行MTX和paeoniflorin衍生物的联合治疗.
主要成果:
- 在膜GRK2表达和MTX疗效之间发现了负相关性,而A2AAR表达显示了正相关性.
- 升高的GRK2促进了ERK通路的激活,抑制了MTX诱导的亡和免疫抑制.
- 在不响应MTX的CIA大鼠中,组合疗法改善了响应率,达到77.79%-88.89%.
结论:
- 过度的膜GRK2损害了A2AAR的分布,削弱了MTX在RA中的抗炎作用.
- 同时使用MTX和paeoniflorin衍生物是一种有希望的策略,可以提高RA患者的治疗反应,特别是那些对MTX无反应的患者.
相关概念视频
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
454
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
454
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
435
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
435
01:27Combined Effects of Drugs: Synergism
6.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
6.7K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
874
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
874
01:11Genome-wide Association Studies-GWAS
15.2K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
15.2K
01:17Phase II Reactions: Methylation Reactions
655
Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
655